Roy King

1.6k total citations
37 papers, 1.0k citations indexed

About

Roy King is a scholar working on Oncology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Roy King has authored 37 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Dermatology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Roy King's work include Cutaneous Melanoma Detection and Management (14 papers), Cancer and Skin Lesions (10 papers) and Genetic and rare skin diseases. (5 papers). Roy King is often cited by papers focused on Cutaneous Melanoma Detection and Management (14 papers), Cancer and Skin Lesions (10 papers) and Genetic and rare skin diseases. (5 papers). Roy King collaborates with scholars based in United States, Canada and Russia. Roy King's co-authors include Martín C. Mihm, Paul B. Googe, David E. Fisher, Katherine N. Weilbaecher, Robert N. Page, Gaël McGill, Klaus J. Busam, Víctor G. Prieto, Juan Rosaí and Dina Gutkowicz–Krusin and has published in prestigious journals such as The Journal of Infectious Diseases, American Journal Of Pathology and The American Journal of Surgical Pathology.

In The Last Decade

Roy King

36 papers receiving 990 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy King United States 16 565 261 233 231 173 37 1.0k
Michael Tronnier Germany 21 557 1.0× 293 1.1× 229 1.0× 325 1.4× 186 1.1× 93 1.1k
Michael S. Rabkin United States 15 813 1.4× 310 1.2× 96 0.4× 271 1.2× 262 1.5× 26 1.1k
Guido Massi Italy 17 473 0.8× 225 0.9× 97 0.4× 172 0.7× 177 1.0× 73 1.0k
Gisela Metzler Germany 22 755 1.3× 272 1.0× 111 0.5× 531 2.3× 410 2.4× 83 1.3k
Marco Manfredini Italy 23 473 0.8× 229 0.9× 157 0.7× 588 2.5× 316 1.8× 90 1.4k
Giorgio Annessi Italy 23 466 0.8× 175 0.7× 153 0.7× 519 2.2× 346 2.0× 54 1.2k
C. Guillén Spain 21 598 1.1× 166 0.6× 106 0.5× 599 2.6× 508 2.9× 96 1.2k
Josep Palou Spain 18 871 1.5× 225 0.9× 107 0.5× 444 1.9× 368 2.1× 39 1.1k
Ángel Pizarro Spain 16 407 0.7× 829 3.2× 157 0.7× 197 0.9× 132 0.8× 52 1.3k
Mihm Mc United States 13 368 0.7× 273 1.0× 99 0.4× 176 0.8× 110 0.6× 20 915

Countries citing papers authored by Roy King

Since Specialization
Citations

This map shows the geographic impact of Roy King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy King more than expected).

Fields of papers citing papers by Roy King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy King. The network helps show where Roy King may publish in the future.

Co-authorship network of co-authors of Roy King

This figure shows the co-authorship network connecting the top 25 collaborators of Roy King. A scholar is included among the top collaborators of Roy King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy King. Roy King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Roy, et al.. (2024). IgM-mediated epidermolysis bullosa acquisita. JAAD Case Reports. 46. 49–51.
2.
King, Roy, et al.. (2020). Malignant circumscribed acral hypokeratosis. JAAD Case Reports. 6(3). 214–216. 5 indexed citations
3.
King, Roy. (2011). Lentiginous Melanoma. Archives of Pathology & Laboratory Medicine. 135(3). 337–341. 22 indexed citations
4.
Monheit, Gary D., Armand B. Cognetta, Laura K. Ferris, et al.. (2010). The Performance of MelaFind. Archives of Dermatology. 147(2). 188–188. 165 indexed citations
5.
Page, Roy C., et al.. (2009). Myxoid atypical fibroxanthoma: a previously undescribed variant. Journal of Cutaneous Pathology. 36(11). 1177–1184. 20 indexed citations
6.
Page, Robert N., et al.. (2009). Syringomatous adenoma of the nipple occurring within a supernumerary breast: a case report. Journal of Cutaneous Pathology. 36(11). 1206–1209. 15 indexed citations
7.
Abbasi, Naheed R., Molly Yancovitz, Dina Gutkowicz–Krusin, et al.. (2008). Utility of Lesion Diameter in the Clinical Diagnosis of Cutaneous Melanoma. Archives of Dermatology. 144(4). 469–74. 42 indexed citations
8.
Walters, Ruth F, Pamela A. Groben, Klaus J. Busam, et al.. (2007). Consumption of the Epidermis: A Criterion in the Differential Diagnosis of Melanoma and Dysplastic Nevi That is Associated With Increasing Breslow Depth and Ulceration. American Journal of Dermatopathology. 29(6). 527–533. 14 indexed citations
9.
King, Roy, et al.. (2006). Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus‐like cutaneous metastases. Journal of Cutaneous Pathology. 34(8). 629–633. 14 indexed citations
10.
King, Roy, Robert N. Page, Paul B. Googe, & Martín C. Mihm. (2005). Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus. Modern Pathology. 18(10). 1397–1401. 40 indexed citations
11.
Shia, Jinru, Jing Qin, Robert A. Erlandson, et al.. (2005). Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 447(5). 828–834. 22 indexed citations
12.
King, Roy, Paul B. Googe, Robert N. Page, & Martín C. Mihm. (2005). Melanocytic lesions associated with dermatofibromas: a spectrum of lesions ranging from junctional nevus to malignant melanoma in situ. Modern Pathology. 18(8). 1043–1047. 14 indexed citations
13.
Page, Robert N., Roy King, Martín C. Mihm, & Paul B. Googe. (2004). Microphthalmia transcription factor and NKI/C3 expression in cellular neurothekeoma. Modern Pathology. 17(2). 230–234. 43 indexed citations
14.
King, Roy, Robert N. Page, & Paul B. Googe. (2003). Desmoplastic Seborrheic Keratosis. American Journal of Dermatopathology. 25(3). 210–214. 1 indexed citations
15.
Googe, Paul B. & Roy King. (2001). Herpesvirus Infection of Seborrheic Keratoses. American Journal of Dermatopathology. 23(2). 146–148. 7 indexed citations
16.
King, Roy, Paul B. Googe, Katherine N. Weilbaecher, Martín C. Mihm, & David E. Fisher. (2001). Microphthalmia Transcription Factor Expression in Cutaneous Benign, Malignant Melanocytic, and Nonmelanocytic Tumors. The American Journal of Surgical Pathology. 25(1). 51–57. 128 indexed citations
17.
King, Roy, et al.. (2001). Postsurgical Dermal Lymphedema Clinically Mimicking Inflammatory Breast Carcinoma. Archives of Dermatology. 137(7). 969–969. 6 indexed citations
18.
King, Roy, Klaus J. Busam, & Juan Rosaí. (1999). Metastatic Malignant Melanoma Resembling Malignant Peripheral Nerve Sheath Tumor. The American Journal of Surgical Pathology. 23(12). 1499–1499. 52 indexed citations
19.
King, Roy, Julie E. Gough, Allan Ronald, et al.. (1996). An Immunohistochemical Analysis of Naturally Occurring Chancroid. The Journal of Infectious Diseases. 174(2). 427–430. 32 indexed citations
20.
King, Roy, Guillermo Quinonez, & James Gough. (1996). Fine Needle Aspiration Biopsy Diagnosis of a Gastrointestinal Stromal Tumor Utilizing Transmission Electron Microscopy. Acta Cytologica. 40(3). 581–584. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026